APOE and diabetes mellitus: NOX1 expression is increased in the plaques of patients with cardiovascular events or diabetes [19], and deleting NOX1 reduces lesion area in both apolipoprotein E deficient (ApoE−/−) mice and in ApoE−/− mice after induction of diabetes [20,21].